ETF Copilot
Health & Biotech

Is PTH a good investment?

Updated October 9, 2026

Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PTH 5.0 out of 10 — highest on Growth (9.7), lowest on Quality (0.1). It trades at 28.2 times earnings, against its own median of 28.3. Its ten largest holdings are 37% of the fund.

What stands out in PTH's data

Tracks U.S. healthcare stocks selected for trends in biotech and medical innovation.

Profit margins trail most peers — the fund relies on price momentum, not earnings strength.

EBITDA margin of 8.6% lags the category median of 20.5%, behind most peers. It holds 52 stocks and returned 22% annualized over three years.

A momentum-driven sleeve for healthcare exposure, built on biotech innovation and recent market strength.

Why did PTH move this week? It fell 2.4% in the week to October 9, 2026 — 10X Genomics and Twist Bioscience drove it

PTH fell 2.4% in the week to October 9, 2026. The holdings that moved it most were 10X Genomics (−13.7%), Twist Bioscience (−15.3%) and Insmed (−9.5%); Oscar Health (+7.9%) pushed the other way.

How is PTH rated? ETF Copilot scores Invesco Dorsey Wright Healthcare Momentum ETF (PTH) 5.0 out of 10

As of October 9, 2026, ETF Copilot scores Invesco Dorsey Wright Healthcare Momentum ETF (PTH) 5.0 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

  • Overall: 5.0 / 10
  • Growth: 9.7 / 10
  • Risk: 1.4 / 10
  • Quality: 0.1 / 10
  • Return: 5.9 / 10

Is PTH expensive right now? It trades at 28.2 times earnings, against its own median of 28.3

As of October 9, 2026, PTH is cheaper than 57% of its own last 7 years.

Trailing 12 months, built from PTH's holdings. How we calculate this →

What's inside PTH?

What's inside PTH: Size (Large 10%, Mid 52%, Small 39%); Geography (International 5%, US 95%); AI 2.0%.

What are PTH's top holdings? The ten largest are 37% of the fund

Iovance Biotherapeutics, 10X Genomics, Natera, Tenet Healthcare, Guardant Health, Revolution Medicines, Roivant Sciences, Insmed, Twist Bioscience and Medpace are PTH's largest holdings, in that order.

Less concentrated than 67% of Health & Biotech ETFs.

Half of PTH's weight sits in its 16 largest positions, and once those weights are taken into account it behaves like 41 equally weighted holdings.

What is PTH's expense ratio? 0.74% a year

As of October 9, 2026, PTH charges 0.74% a year, yields 2.60% and holds $280M in assets across 52 positions.

Invesco Dorsey Wright Healthcare Momentum ETF (PTH) — cost, income and size
MeasurePTH
Expense ratio0.74%
Dividend yield2.60%
Assets under management$280M
Holdings52

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Cite this

ETF Copilot, “Invesco Dorsey Wright Healthcare Momentum ETF (PTH) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/pth

ETF Copilot Pro unlocks PTH's price and what each holding weighs.

Try Pro free →